CD274 and non-small cell lung carcinoma: It was discovered that NSCLC patients who exhibited resistance to anti‐PD‐L1 demonstrated decreased levels of LSD2 and PD‐L1 expression, as well as increased PD‐L1 K162 methylation and SETD7 expression.87